Sparfloxacin — CAS 110871-86-8

Sparfloxacin is a third-generation fluoroquinolone antibiotic with a broad spectrum of antibacterial activity, particularly effective against atypical respiratory pathogens. It inhibits bacterial DNA gyrase and topoisomerase IV. Mediocon Inc manufactures GMP-compliant Sparfloxacin API at its Aurangabad facility.

• Community-acquired pneumonia
• Atypical pneumonia treatment
• Chronic bronchitis infections
• Upper and lower respiratory tract infections

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support